Virtual Digital Psychotherapist App–Based Treatment in Patients With Methamphetamine Use Disorder (Echo-APP): Single-Arm Pilot Feasibility and Efficacy Study
JMIR mHealth and uHealth · 2023-01-31 · 11 · e40373
DOI: 10.2196/40373 ↗At a glance
Journal article in JMIR mHealth and uHealth, published online on 2023-01-31. Written by Tianzhen Chen and 9 co-authors. Institution: Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Major MEDLINE topics: Methamphetamine, Amphetamine-Related Disorders. Cited 21 times so far (Crossref); 38 references. The full text is freely available in PubMed Central.
Abstract (original language)
Background
Substance use disorder is one of the severe public health problems worldwide. Inequitable resources, discrimination, and physical distances limit patients’ access to medical help. Automated conversational agents have the potential to provide in-home and remote therapy. However, automatic dialogue agents mostly use text and other methods to interact, which affects the interaction experience, treatment immersion, and clinical efficacy.
Objective
The aim of this paper is to describe the design and development of Echo-APP, a tablet-based app with the function of a virtual digital psychotherapist, and to conduct a pilot study to explore the feasibility and preliminary efficacy results of Echo-APP for patients with methamphetamine use disorder.
Methods
Echo-APP is an assessment and rehabilitation program developed for substance use disorder (SUD) by a team of clinicians, psychotherapists, and computer experts. The program is available for Android tablets. In terms of assessment, the focus is on the core characteristics of SUD, such as mood, impulsivity, treatment motivation, and craving level. In terms of treatment, Echo-APP provides 10 treatment units, involving awareness of addiction, motivation enhancement, emotion regulation, meditation, etc. A total of 47 patients with methamphetamine dependence were eventually enrolled in the pilot study to receive a single session of the Echo-APP–based motivational enhancement treatment. The outcomes were assessed before and after the patients’ treatment, including treatment motivation, craving levels, self-perception on the importance of drug abstinence, and their confidence in stopping the drug use.
Results
In the pilot study, scores on the Stages of Change Readiness and Treatment Eagerness Scale and the questionnaire on motivation for abstaining from drugs significantly increased after the Echo-APP–based treatment (P
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Shanghai Key Laboratory of Psychotic Disorders, Shanghai, China.
- Center for Excellence in Brain Science and Intelligence Technology (CEBSIT), Chinese Academy of Sciences, Shanghai, China.
ORCID profiles: Tianzhen Chen, Liyu Chen, Shuo Li, Jiang Du, Hang Su, Haifeng Jiang, Qianying Wu, Lei Zhang, Jiayi Bao, Min Zhao
Cite
APA
Chen, T., Chen, L., Li, S., Du, J., Su, H., Jiang, H., Wu, Q., Zhang, L., Bao, J., & Zhao, M. (2023). Virtual Digital Psychotherapist App–Based Treatment in Patients With Methamphetamine Use Disorder (Echo-APP): Single-Arm Pilot Feasibility and Efficacy Study. JMIR mHealth and uHealth, 11, e40373. https://doi.org/10.2196/40373
Vancouver
Chen T, Chen L, Li S, Du J, Su H, Jiang H, et al. Virtual Digital Psychotherapist App–Based Treatment in Patients With Methamphetamine Use Disorder (Echo-APP): Single-Arm Pilot Feasibility and Efficacy Study. JMIR mHealth and uHealth. 2023;11:e40373. doi:10.2196/40373
BibTeX
@article{Chen2023,
author = {Chen, Tianzhen and Chen, Liyu and Li, Shuo and Du, Jiang and Su, Hang and Jiang, Haifeng and Wu, Qianying and Zhang, Lei and Bao, Jiayi and Zhao, Min},
title = {Virtual Digital Psychotherapist App–Based Treatment in Patients With Methamphetamine Use Disorder (Echo-APP): Single-Arm Pilot Feasibility and Efficacy Study},
journal = {JMIR mHealth and uHealth},
year = {2023},
volume = {11},
pages = {e40373},
doi = {10.2196/40373}
}
EUVIMED